Asabys Partners, a Pan-European Venture Capital firm specialized in investments in the life sciences and health sectors, and Alantra, an investment banking and asset management firm, have reached an agreement by which Alantra becomes a strategic partner of Asabys through the acquisition of a 35% stake in the firm.

The transaction has the support of Banc Sabadell as one of the promoters of the project and anchor investor in Asabys’ first vehicle ("Sabadell Asabys Health Innovation Investments SCR SA"). As part of the agreement, Alantra will invest in the first vehicle of Asabys and will support the search for new investors and the internationalization of the project.